RIDGELAND, MS – February 15, 2021 – Legacy-Xspire Holdings, LLC, parent of Wraser Pharmaceuticals, Xspire Pharma and Gentex Pharma (collectively “Legacy-Xspire”), a portfolio company of HealthEdge Investment Partners, LLC (“HealthEdge”), today announced the appointment of Gregory J. Stokes to both the Board of Managers and the position of Chief Executive Officer.

Mr. Stokes joins Legacy-Xspire with 30 years of experience in the pharmaceutical industry including positions in Sales, Marketing, Business Development and Executive Management.  In addition to operational and strategic expertise, Mr. Stokes has more than 15 years of experience in growth equity, leading multiple successful investments.

In speaking for the Board of Managers, HealthEdge Operating Partner Robert Cunard shared “We are happy to announce the addition of Greg Stokes to lead the Legacy-Xspire portfolio, with his proven business development, management and leadership skills, Greg is the right person to drive the business forward.”

In accepting the role, Mr. Stokes commented, “I am very eager and excited to join the experienced and talented team managing the Legacy-Xspire portfolio.  This is a group that has built an incredibly strong portfolio of products with multiple opportunities for success in various channels of business.  In upcoming years, we expect to see significant organic growth, as well as take advantage of opportunities to acquire additional products and companies in line with our corporate objectives.”

Mr. Stokes holds a Bachelor of Arts degree from the University of Pennsylvania in addition to Masters of Business Administration and Juris Doctorate degrees from Rutgers University.

ABOUT LEGACY-XSPIRE HOLDINGS
Legacy-Xspire Holdings, LLC, which consists of Wraser Pharmaceuticals and Xspire Pharma, is a unique pharmaceutical company that focuses on proprietary physician-driven brands and high-value late lifecycle generics.  Legacy continues to seek opportunities to leverage its sales professionals and the operational expertise of its diverse group of seasoned pharmaceutical experts.

ABOUT HEALTHEDGE INVESTMENT PARTNERS
HealthEdge Investment Partners, LLC is an operation-oriented private equity firm founded in 2005 that focuses exclusively on the healthcare industry. HealthEdge seeks to achieve superior returns by investing in businesses that benefit from the knowledge, experience, and network of relationships of its partners. HealthEdge’s partners have more than 100 years of combined operating experience in healthcare as CEOs and investors.